{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$0.960 vs. cons $0.958",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "North America revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$810M vs. cons $814.7M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "China revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$138M vs. cons $138.0M",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 adjusted EPS",
      "prediction": "BETTER",
      "answer": "guide $3.70-$4.00 vs. cons $3.767",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 sales",
      "prediction": "BETTER",
      "answer": "guide $3.90B-$4.00B vs. cons $3.907B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 price realization commentary",
      "prediction": "UNCHANGED",
      "answer": "price benefit begins Q3 vs. cons UNVERIFIED",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -4.5,
  "day1_confidence": "LOW",
  "day5_residual_pct": -2.5,
  "day5_path": "FADE",
  "day5_rationale": "FADE \u2014 in-line/maintain leaves forward concerns unresolved",
  "day5_confidence": "LOW"
}